Cellular growth factors and its kinase pathways, such as epidermal growth factor receptor (EGFR) [6], have been used as cancer therapies for decades [7, 8] and are now proposed for central nervous system (CNS) neurodegenerative diseases [9, 10]. This evidence concerns the gene EGFR and neurodegenerative disease.